Recombinant Human HECTD1 Protein，GST

HECTD1, a member of the HECT (Homologous to the E6-AP Carboxyl Terminus) E3 ubiquitin ligase family, plays a critical role in regulating various cellular processes, including protein degradation, cell cycle progression, and signal transduction. Dysregulation of HECTD1 has been implicated in several diseases, particularly cancer, where abnormal ubiquitination leads to the stabilization of oncogenes or the degradation of tumor suppressors. Recent studies have revealed that HECTD1 may also be involved in developmental processes and neurodegenerative diseases, highlighting its importance in maintaining cellular homeostasis. Given its multifaceted functions, the characterization and understanding of HECTD1's mechanisms of action are vital. Researchers are increasingly focusing on the functional analysis of recombinant HECTD1 proteins to elucidate the specific pathways it influences. Recombinant protein studies allow for the exploration of HECTD1's enzymatic activity, substrate specificity, and interactions with other proteins, providing insights into its role within the ubiquitin-proteasome system. Additionally, the potential therapeutic implications of modulating HECTD1 activity render its investigation particularly relevant in biomedical research. Overall, studying recombinant HECTD1 proteins contributes to a deeper understanding of ubiquitin ligase functions and highlights novel avenues for therapeutic intervention in related pathologies.